High seroprevalence after the second wave of SARS-COV2 respiratory infection in a small settlement on the northern coastal of Peru.

Descripción del Articulo

Objective: a) to assess the seroprevalence of SARS-CoV-2 at the end of the second wave; b) to determine the distribution by age group and health determinants associated with seropositivity. Material and Methodology: A study performed in a Tumbes' settlement between December 2021–January 2022 sa...

Descripción completa

Detalles Bibliográficos
Autores: Toledo, Angie K., León-Jimenez, Franco, Cavalcanti, Sofia, Vilchez-Barreto, Percy, Reto, Narcisa, Vega, Jessica, Bolivar, Lucia M, Rhor, Eva M., Ypanaque, Jhon, Silva-Marchan, Henry, Moyano, Luz M., Neuroepidemiology and Science of Life Working Group (NESL)
Formato: artículo
Fecha de Publicación:2024
Institución:Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo
Repositorio:Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo
Lenguaje:español
OAI Identifier:oai:cmhnaaa_ojs_cmhnaaa.cmhnaaa.org.pe:article/2287
Enlace del recurso:https://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/2287
Nivel de acceso:acceso abierto
Materia:covid-19
seroprevalence
Tumbes
SARS-CoV-2
COVID-19
Peru
id REVCMH_bcd67d2d29bf598e9c6527dcd0e2a0b7
oai_identifier_str oai:cmhnaaa_ojs_cmhnaaa.cmhnaaa.org.pe:article/2287
network_acronym_str REVCMH
network_name_str Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo
repository_id_str
dc.title.none.fl_str_mv High seroprevalence after the second wave of SARS-COV2 respiratory infection in a small settlement on the northern coastal of Peru.
Alta seroprevalencia tras la segunda oleada de infección respiratoria por SARS-COV2 en un pequeño asentamiento de la costa norte de Perú.
title High seroprevalence after the second wave of SARS-COV2 respiratory infection in a small settlement on the northern coastal of Peru.
spellingShingle High seroprevalence after the second wave of SARS-COV2 respiratory infection in a small settlement on the northern coastal of Peru.
Toledo, Angie K.
covid-19
seroprevalence
Tumbes
SARS-CoV-2
COVID-19
SARS-CoV-2
Peru
seroprevalence
title_short High seroprevalence after the second wave of SARS-COV2 respiratory infection in a small settlement on the northern coastal of Peru.
title_full High seroprevalence after the second wave of SARS-COV2 respiratory infection in a small settlement on the northern coastal of Peru.
title_fullStr High seroprevalence after the second wave of SARS-COV2 respiratory infection in a small settlement on the northern coastal of Peru.
title_full_unstemmed High seroprevalence after the second wave of SARS-COV2 respiratory infection in a small settlement on the northern coastal of Peru.
title_sort High seroprevalence after the second wave of SARS-COV2 respiratory infection in a small settlement on the northern coastal of Peru.
dc.creator.none.fl_str_mv Toledo, Angie K.
León-Jimenez, Franco
Cavalcanti, Sofia
Vilchez-Barreto, Percy
Reto, Narcisa
Vega, Jessica
Bolivar, Lucia M
Rhor, Eva M.
Ypanaque, Jhon
Silva-Marchan, Henry
Moyano, Luz M.
Neuroepidemiology and Science of Life Working Group (NESL)
author Toledo, Angie K.
author_facet Toledo, Angie K.
León-Jimenez, Franco
Cavalcanti, Sofia
Vilchez-Barreto, Percy
Reto, Narcisa
Vega, Jessica
Bolivar, Lucia M
Rhor, Eva M.
Ypanaque, Jhon
Silva-Marchan, Henry
Moyano, Luz M.
Neuroepidemiology and Science of Life Working Group (NESL)
author_role author
author2 León-Jimenez, Franco
Cavalcanti, Sofia
Vilchez-Barreto, Percy
Reto, Narcisa
Vega, Jessica
Bolivar, Lucia M
Rhor, Eva M.
Ypanaque, Jhon
Silva-Marchan, Henry
Moyano, Luz M.
Neuroepidemiology and Science of Life Working Group (NESL)
author2_role author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv covid-19
seroprevalence
Tumbes
SARS-CoV-2
COVID-19
SARS-CoV-2
Peru
seroprevalence
topic covid-19
seroprevalence
Tumbes
SARS-CoV-2
COVID-19
SARS-CoV-2
Peru
seroprevalence
description Objective: a) to assess the seroprevalence of SARS-CoV-2 at the end of the second wave; b) to determine the distribution by age group and health determinants associated with seropositivity. Material and Methodology: A study performed in a Tumbes' settlement between December 2021–January 2022 sampled individuals over 2 years old from one to every four households. We collected finger-prick blood samples and conducted symptom surveys. Results: The adjusted seroprevalence after the second wave increased by twofold (50.15%, 95% CI[45.92–54.40]), compared with the first wave (24.82 %, 95%CI [22.49–27.25]). Females maintained a higher seroprevalence (53.89; 95% CI[48.48-59.23]) vs. 45.49; 95% CI [38.98-52.12], p=0.042) compared to males. Those under 18 years of age had the highest IgG seropositivity: the 12–17 age group during the second wave (85.14%) and the 2–11 age group (25.25%) during the first wave. Nasal congestion and cough were symptoms associated with seropositivity, unlike the first wave. Conclusions: The seroprevalence of COVID-19 increased by twofold compared to the initial wave in Tumbes region. Infrastructure constraints, restricted human resources, and supply limitations in healthcare facilities made the Peruvian health system collapse. The epidemiological surveillance network should incorporate mHealth tools for real-time notifiable disease information. Working alongside the community will let us improve interventions for preventing or controlling new pandemics.
publishDate 2024
dc.date.none.fl_str_mv 2024-04-01
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/2287
10.35434/rcmhnaaa.2024.171.2287
url https://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/2287
identifier_str_mv 10.35434/rcmhnaaa.2024.171.2287
dc.language.none.fl_str_mv spa
language spa
dc.relation.none.fl_str_mv https://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/2287/914
dc.rights.none.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Cuerpo Médico del Hospital Nacional Almanzor Aguinaga Asenjo
publisher.none.fl_str_mv Cuerpo Médico del Hospital Nacional Almanzor Aguinaga Asenjo
dc.source.none.fl_str_mv Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo; Vol. 17 No. 1 (2024): Early Publication; e2287
Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo; Vol. 17 Núm. 1 (2024): Rev. Cuerpo Med. HNAAA, Enero - Marzo; e2287
2227-4731
2225-5109
10.35434/rcmhnaaa.2024.171
reponame:Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo
instname:Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo
instacron:HNAAA
instname_str Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo
instacron_str HNAAA
institution HNAAA
reponame_str Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo
collection Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1842629794740568064
spelling High seroprevalence after the second wave of SARS-COV2 respiratory infection in a small settlement on the northern coastal of Peru.Alta seroprevalencia tras la segunda oleada de infección respiratoria por SARS-COV2 en un pequeño asentamiento de la costa norte de Perú.Toledo, Angie K. León-Jimenez, Franco Cavalcanti, Sofia Vilchez-Barreto, Percy Reto, Narcisa Vega, Jessica Bolivar, Lucia M Rhor, Eva M. Ypanaque, Jhon Silva-Marchan, Henry Moyano, Luz M. Neuroepidemiology and Science of Life Working Group (NESL)covid-19seroprevalenceTumbesSARS-CoV-2COVID-19SARS-CoV-2PeruseroprevalenceObjective: a) to assess the seroprevalence of SARS-CoV-2 at the end of the second wave; b) to determine the distribution by age group and health determinants associated with seropositivity. Material and Methodology: A study performed in a Tumbes' settlement between December 2021–January 2022 sampled individuals over 2 years old from one to every four households. We collected finger-prick blood samples and conducted symptom surveys. Results: The adjusted seroprevalence after the second wave increased by twofold (50.15%, 95% CI[45.92–54.40]), compared with the first wave (24.82 %, 95%CI [22.49–27.25]). Females maintained a higher seroprevalence (53.89; 95% CI[48.48-59.23]) vs. 45.49; 95% CI [38.98-52.12], p=0.042) compared to males. Those under 18 years of age had the highest IgG seropositivity: the 12–17 age group during the second wave (85.14%) and the 2–11 age group (25.25%) during the first wave. Nasal congestion and cough were symptoms associated with seropositivity, unlike the first wave. Conclusions: The seroprevalence of COVID-19 increased by twofold compared to the initial wave in Tumbes region. Infrastructure constraints, restricted human resources, and supply limitations in healthcare facilities made the Peruvian health system collapse. The epidemiological surveillance network should incorporate mHealth tools for real-time notifiable disease information. Working alongside the community will let us improve interventions for preventing or controlling new pandemics.Objetivo: a) evaluar la seroprevalencia de SARS-CoV-2 al final de la segunda ola; b) determinar su distribución por grupos de edad y los determinantes de salud asociados a la seropositividad. Materiales y Método: Un estudio realizado en un asentamiento humano de Tumbes entre diciembre de 2021 y enero de 2022 muestreó individuos mayores de 2 años en uno de cada cuatro hogares. Se tomó muestras de sangre por punción-digital y se realizó encuestas sintomáticas. Resultados: La seroprevalencia ajustada tras la segunda ola se duplicó (50.15%, IC 95% [45,92-54,40]), comparado con la primera ola (24.82%, IC 95% [22,49-27,25]). Las mujeres mantuvieron una mayor seroprevalencia (53.89; IC 95% [48,48-59,23] vs.  45.49; IC 95% [38,98-52,12], p = 0,042) comparado con los hombres. Los menores de 18 años presentaron mayor seropositividad IgG: el grupo de 12-17 años durante la segunda ola (85,14%) y el grupo de 2-11 años (25,25%) durante la primera ola. Congestión nasal y tos estuvieron asociados a la seropositividad, a diferencia de la primera oleada. Conclusiones: La seroprevalencia de COVID-19 se duplicó en comparado con la primera ola en Tumbes. Las limitaciones de infraestructura, los recursos humanos restringidos y las limitaciones de abastecimiento en los establecimientos de salud hicieron colapsar el sistema de salud peruano. La red de vigilancia epidemiológica debería incorporar herramientas de mhealth para obtener información en tiempo real sobre las enfermedades. de declaración obligatoria. Trabajar junto a la comunidad nos permitirá mejorar las intervenciones para prevenir o controlar nuevas pandemias.Cuerpo Médico del Hospital Nacional Almanzor Aguinaga Asenjo2024-04-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/228710.35434/rcmhnaaa.2024.171.2287Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo; Vol. 17 No. 1 (2024): Early Publication; e2287Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo; Vol. 17 Núm. 1 (2024): Rev. Cuerpo Med. HNAAA, Enero - Marzo; e22872227-47312225-510910.35434/rcmhnaaa.2024.171reponame:Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjoinstname:Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjoinstacron:HNAAAspahttps://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/2287/914Derechos de autor 2024 Angie K. Toledo, Franco León-Jimenez, Sofia Cavalcanti, Percy Vilchez-Barreto, Narcisa Reto, Jessica Vega, Lucia M Bolivar, Matilde Rhor, Jhon Ypanaque, Henry Silva, Luz M. Moyano, Neuroepidemiology and Science of Life Working Group (NESL)https://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessoai:cmhnaaa_ojs_cmhnaaa.cmhnaaa.org.pe:article/22872025-05-14T10:42:36Z
score 12.660197
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).